Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?

Similar Items

• Intra-patient heterogeneity of BRAF mutation status: fact or fiction?
  od: Menzies, A M, i dr.
  Izdano: (2014)
• Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations
  od: Heinzerling, L, i dr.
  Izdano: (2013)
• Reply to “Successful Target Attainment of Telavancin at Elevated MICs: Fact or Fiction?”
  od: Lodise, Thomas P., i dr.
  Izdano: (2012)
• Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice
  od: Heinzerling, L, i dr.
  Izdano: (2013)
• Biological weapons: the facts not the fiction
  od: Holdstock, Douglas
  Izdano: (2002)